Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other Accumulated Expenses: 2018

  • Soleno Therapeutics' Other Accumulated Expenses was N/A to $349,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $349,000, marking a year-over-year change of. This contributed to the annual value of $349,000 for FY2018, which is N/A change from last year.
  • Soleno Therapeutics' Other Accumulated Expenses amounted to $349,000 in Q4 2018.
  • Soleno Therapeutics' 5-year Other Accumulated Expenses high stood at $349,000 for Q4 2018, and its period low was $349,000 during Q4 2018.
  • Its 1-year average for Other Accumulated Expenses is $349,000, with a median of $349,000 in 2018.